Why Is UBS (UBS) Up 8.8% Since Last Earnings Report?

UBS reported robust Q2 2025 results, with net profit attributable to shareholders more than doubling year-over-year to $2.39 billion on 1.7% higher revenues of $12.11 billion, primarily driven by strong performances in Global Wealth Management, Asset Management, and Investment Bank, despite increased credit loss expenses. The bank achieved a 13.5% return on CET1 capital, and its shares have since gained 8.8%, outperforming the S&P 500. Looking ahead, management targets $13 billion in gross cost savings by 2026 and a 15% underlying RoCET1 exit rate, even as analyst consensus estimates have seen a significant 19.51% downward revision in the past month, presenting a mixed outlook despite the stock's Zacks #1 Strong Buy rating.

Analysis

UBS Group demonstrated robust performance in its Q2 2025 earnings, with net profit more than doubling to $2.39 billion year-over-year, driven by strong operating profit growth in its Global Wealth Management, Asset Management, and Investment Bank divisions. This result was achieved on a modest 1.7% revenue increase to $12.11 billion, highlighting effective cost control as operating expenses fell 5.6%. Key headwinds included a 71.6% surge in credit loss expenses to $163 million and a 10.1% decline in Personal & Corporate Banking profit. The bank's return on CET1 capital improved significantly to 13.5% from 5.9% a year prior, although absolute CET1 capital declined 4.4% to $72.7 billion. Despite the strong report and a subsequent 8.8% share price outperformance against the S&P 500, a significant dichotomy exists, as analyst consensus estimates for the company have been revised downward by 19.51% in the past month. This conflicting signal is further complicated by a Zacks Rank #1 (Strong Buy) rating juxtaposed with poor 'F' grades for Growth and Momentum. Management has set ambitious long-term targets, including approximately $13 billion in gross cost savings by 2026 and an underlying RoCET1 exit rate of 15%, framing a positive long-term narrative contingent on successful execution of its post-merger strategy.

Key Decisions for Investors

• Investors should weigh the strong reported Q2 profitability and bullish long-term management targets against the significant 19.51% downward revision in near-term analyst consensus estimates, which suggests potential execution risk or un-modeled headwinds.
• Monitor progress toward the guided $13 billion in gross cost savings and the CET1 capital ratio, as achieving these is critical to reaching the targeted 15% underlying RoCET1 by 2026 and validating the post-merger investment thesis.
• Given the conflicting signals of a 'Strong Buy' rating versus poor fundamental scores and falling estimates, a hold strategy may be prudent, allowing time to assess whether the company can translate its ambitious synergy targets into sustainable earnings that reverse the negative estimate trend.